Pharma & Healthcare
Ustekinumab Biosimilars
- Types
- Subcutaneous Injection · Intravenous Infusion
- Applications
- Crohn's Disease · Ulcerative Colitis · Plaque Psoriasis
5 editions27 December 2025
$4,950Single user · USD · Market Analysis & ForecastExplore product: Ustekinumab BiosimilarsCompare research options for Ustekinumab Biosimilars